Return On Equity in % of Checkpoint Therapeutics, Inc. from Q2 2017 to Q1 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Checkpoint Therapeutics, Inc. quarterly and annual Return On Equity history and change rate from Q2 2017 to Q1 2025.
  • Checkpoint Therapeutics, Inc. Return On Equity for the quarter ending 31 Mar 2025 was 916%, a 187% increase year-over-year.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2024 was 439%, a 64.2% increase from 2023.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2023 was 267%.
  • Checkpoint Therapeutics, Inc. annual Return On Equity for 2022 was -3,652%, a 2941% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Checkpoint Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 916% +597% +187% 01 Jan 2025 31 Mar 2025
Q4 2024 439% +172% +64% 01 Oct 2024 31 Dec 2024
Q3 2024 360% +104% +41% 01 Jul 2024 30 Sep 2024
Q2 2024 292% -61% -17% 01 Apr 2024 30 Jun 2024
Q1 2024 319% -314% -50% 01 Jan 2024 31 Mar 2024
Q4 2023 267% +3,919% 01 Oct 2023 31 Dec 2023
Q3 2023 256% +765% 01 Jul 2023 30 Sep 2023
Q2 2023 354% +627% 01 Apr 2023 30 Jun 2023
Q1 2023 633% +806% 01 Jan 2023 31 Mar 2023
Q4 2022 -3,652% -3,531% -2,941% 01 Oct 2022 31 Dec 2022
Q3 2022 -509% -432% -566% 01 Jul 2022 30 Sep 2022
Q2 2022 -273% -206% -305% 01 Apr 2022 30 Jun 2022
Q1 2022 -173% -98% -132% 01 Jan 2022 31 Mar 2022
Q4 2021 -120% -30% -34% 01 Oct 2021 31 Dec 2021
Q3 2021 -76% +24% +24% 01 Jul 2021 30 Sep 2021
Q2 2021 -67% +89% +57% 01 Apr 2021 30 Jun 2021
Q1 2021 -75% +107% +59% 01 Jan 2021 31 Mar 2021
Q4 2020 -90% +161% +64% 01 Oct 2020 31 Dec 2020
Q3 2020 -101% +239% +70% 01 Jul 2020 30 Sep 2020
Q2 2020 -156% +107% +41% 01 Apr 2020 30 Jun 2020
Q1 2020 -182% +30% +14% 01 Jan 2020 31 Mar 2020
Q4 2019 -251% -80% -47% 01 Oct 2019 31 Dec 2019
Q3 2019 -340% -201% -145% 01 Jul 2019 30 Sep 2019
Q2 2019 -263% -136% -108% 01 Apr 2019 30 Jun 2019
Q1 2019 -212% -90% -73% 01 Jan 2019 31 Mar 2019
Q4 2018 -171% -69% -67% 01 Oct 2018 31 Dec 2018
Q3 2018 -139% -44% -47% 01 Jul 2018 30 Sep 2018
Q2 2018 -127% -47% -58% 01 Apr 2018 30 Jun 2018
Q1 2018 -122% 01 Jan 2018 31 Mar 2018
Q4 2017 -102% 01 Oct 2017 31 Dec 2017
Q3 2017 -95% 01 Jul 2017 30 Sep 2017
Q2 2017 -80% 01 Apr 2017 30 Jun 2017

Checkpoint Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 439% +172% +64% 01 Jan 2024 31 Dec 2024
2023 267% +3,919% 01 Jan 2023 31 Dec 2023
2022 -3,652% -3,531% -2,941% 01 Jan 2022 31 Dec 2022
2021 -120% -30% -34% 01 Jan 2021 31 Dec 2021
2020 -90% +161% +64% 01 Jan 2020 31 Dec 2020
2019 -251% -80% -47% 01 Jan 2019 31 Dec 2019
2018 -171% -69% -67% 01 Jan 2018 31 Dec 2018
2017 -102% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.